BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 23548955)

  • 1. [Severe hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone].
    Foppiani L; Raggi F; Tagliabue M; Benso A; Brandolin I; Lo Pinto G
    Recenti Prog Med; 2013 Mar; 104(3):112-5. PubMed ID: 23548955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of euvolemic hyponatremia attributed to SIADH in the hospital setting.
    Peri A; Giuliani C
    Minerva Endocrinol; 2014 Mar; 39(1):33-41. PubMed ID: 24513602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hyponatremia induced by the syndrome of Inappropriate antidiuretic hormone secretion: a multidisciplinary spanish algorithm.
    Runkle I; Villabona C; Navarro A; Pose A; Formiga F; Tejedor A; Poch E
    Nefrologia; 2014; 34(4):439-50. PubMed ID: 25036057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Dos and don'ts' in the management of hyponatremia.
    Aylwin S; Burst V; Peri A; Runkle I; Thatcher N
    Curr Med Res Opin; 2015; 31(9):1755-61. PubMed ID: 26173050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treament of hyponatremia secundary to the syndrome of inappropriate antidiuretic hormone secretion].
    Runkle I; Villabona C; Navarro A; Pose A; Formiga F; Tejedor A; Poch E;
    Med Clin (Barc); 2013 Dec; 141(11):507.e1-507.e10. PubMed ID: 24169317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current considerations in syndrome of inappropriate secretion of antidiuretic hormone/syndrome of inappropriate antidiuresis].
    Velasco Cano MV; Runkle de la Vega I
    Endocrinol Nutr; 2010 May; 57 Suppl 2():22-9. PubMed ID: 21130959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lower doses of tolvaptan in hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion].
    Sánchez Sobrino P; Fernández Catalina P; Lorenzo Solar M; Rego Iraeta A
    Med Clin (Barc); 2015 Aug; 145(3):138-9. PubMed ID: 25543222
    [No Abstract]   [Full Text] [Related]  

  • 8. Elevation of plasma atrial natriuretic peptide in a neurosurgical patient with the syndrome of inappropriate secretion of antidiuretic hormone--case report.
    Yamamoto N; Kuwayama A; Miyamoto N; Seo H; Matsui N
    Neurol Med Chir (Tokyo); 1989 Mar; 29(3):255-8. PubMed ID: 2477734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyponatremia secondary to inappropriate antidiuretic hormone secretion].
    Zamboli P; De Nicola L; Minutolo R; Iodice C; Avino D; Mascia S; D'Angiò P; Calabria M; Conte G
    G Ital Nefrol; 2008; 25(5):554-61. PubMed ID: 18985840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prompt efficacy of tolvaptan in treating hyponatremia of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) closely associated with rupture of a gastric artery aneurysm.
    Yamashita T; Yoshida M; Yamada H; Asano T; Aoki A; Ikoma A; Kusaka I; Kakei M; Ishikawa SE
    Intern Med; 2014; 53(8):845-9. PubMed ID: 24739604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIADH with Severe Hyponatremia in an Elderly Man with Herpes Zoster Infection: A Causal or Casual Association?
    Foppiani L
    Intern Med; 2018 Dec; 57(23):3393-3398. PubMed ID: 29984775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases.
    Tuli G; Tessaris D; Einaudi S; De Sanctis L; Matarazzo P
    J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):288-292. PubMed ID: 28515029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion.
    Gargani L; Schmidt PH; Gheorghiade M
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1505-13. PubMed ID: 22103869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hyponatremia: role of vaptans].
    Hensen J
    Internist (Berl); 2010 Dec; 51(12):1499-509. PubMed ID: 21104220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations regarding the management of hyponatraemia secondary to SIADH.
    Peri A; Combe C
    Best Pract Res Clin Endocrinol Metab; 2012 Mar; 26 Suppl 1():S16-26. PubMed ID: 22469247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tolvaptan on hyponatremia in a dog with syndrome of inappropriate secretion of antidiuretic hormone.
    Yamamoto H; Kimura K; Horikirizono H; Tamura Y; Kambayashi S; Baba K; Okuda M; Mizuno T; Igase M
    J Vet Med Sci; 2023 Oct; 85(10):1047-1051. PubMed ID: 37587049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolvaptan for SIADH in Myelodysplastic Syndrome with Blast Crisis.
    Mali P; Muduganti SR; Mujibur R; Murali N
    WMJ; 2015 Apr; 114(2):66-8. PubMed ID: 26756059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating appropriate antidiuretic hormone secretion, inappropriate antidiuretic hormone secretion and cerebral salt wasting: the common, uncommon, and misnamed.
    Rivkees SA
    Curr Opin Pediatr; 2008 Aug; 20(4):448-52. PubMed ID: 18622203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolvaptan for hyponatremia.
    Hoorn EJ; Zietse R
    N Engl J Med; 2007 Mar; 356(9):961; author reply 962-3. PubMed ID: 17338052
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolvaptan for Treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) in a Child with Corpus Callosum Agenesis.
    Meena AK; Nanda PM; Sharma R; Chakrabarty B; Gulati S
    Indian J Pediatr; 2024 Feb; 91(2):188-190. PubMed ID: 36757652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.